作者: Thomas R. E. Barnes , Christopher J. B. McEvedy , Hazel E. Nelson
DOI: 10.1192/S0007125000298590
关键词:
摘要: A recent challenge in schizophrenia has been the management of patients who have failed to respond not only standard therapeutic regimes but also trials atypical neuroleptics such as clozapine and risperidone. This article focuses on further psychological pharmacological patients.